📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Notices to creditors (MVL)

Phosphate Therapeutics LTD.

active Company no. 07618820 Published 06 August 2026

In short: Phosphate Therapeutics LTD. (company no. 07618820) entered members' voluntary liquidation, a solvent and planned closure, according to a Notices to creditors (MVL) notice published in The London Gazette on 06 August 2026. The office holders are Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 14, appointed 31 July 2026.

The joint liquidators of Phosphate Therapeutics Ltd intend to make a final distribution to creditors, with a proof deadline of 25 September 2026.

Notice details

Company
PHOSPHATE THERAPEUTICS LTD
Company number
07618820
Registered office
12 Wellington Place, Leeds, LS1 4AP
Liquidator(s)
Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 144 Morrison Street, Edinburgh, EH3 8EX
Date of appointment
31 July 2026
Last date for proving
25 September 2026
Contact
Mark Chapman on +44 113 298 2602

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

All notices for Phosphate Therapeutics LTD.

3 Gazette notices on record for company no. 07618820, newest first. The full history, with last filed accounts, is on the Phosphate Therapeutics LTD. company record.

  1. Appointment of liquidators (MVL) 06 Aug 2026
  2. Resolution for winding up (MVL) 06 Aug 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Phosphate Therapeutics LTD. in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Notices to creditors (MVL) for Phosphate Therapeutics LTD. (company no. 07618820) on 06 August 2026.

What does a Notices to creditors (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Who is dealing with the liquidation?

The office holders named in the notice: Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 14, appointed 31 July 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.